Saturday, May 11, 2024 11:57:00 AM
Recent OPTN News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 05/29/2024 07:32:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:16:28 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/20/2024 06:33:49 PM
- Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/17/2024 04:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 01:01:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:08:33 AM
- Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Optinose Announces Reporting Date for First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/10/2024 06:56:52 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 11:09:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:04:59 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 11:03:13 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 11:02:06 AM
- Optinose Announces $55 Million Registered Direct Offering • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Optinose to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps • GlobeNewswire Inc. • 03/15/2024 07:34:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:10:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 09:32:26 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 12:01:38 PM
- Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights • GlobeNewswire Inc. • 03/07/2024 12:00:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 12:00:28 PM
- Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 02/29/2024 09:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:07:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:06:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:05:36 PM
FEATURED Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM